17772-131Level 3
QELBREE (viloxazine hydrochloride)
**Product type:** Human Prescription Drug
**Active ingredient:** VILOXAZINE HYDROCHLORIDE
**Strength:** 100 mg/1
**Dosage form:** Capsule, Extended Release
**Route:** Oral
**Labeler:** Supernus Pharmaceuticals, Inc
**Marketing category:** NDA (NDA211964)
**Pharmacologic class:** Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/17772-131Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.